HIV Care Grant Program - Part B States/Territories Formula and AIDS Drug Assistance Program Formula and AIDS Drug Assistance Program Supplemental Awards: Pacific Islands Jurisdictions

The HIV Care Grant Program Part B States Territories Formula and AIDS Drug Assistance Program Supplemental Awards for Pacific Islands Jurisdictions is administered by the Health Resources and Services Administration within the U.S. Department of Health and Human Services. This federal program operates under the broader HIV Care Formula Grants framework and is designed to support public health systems in addressing HIV treatment and care needs. The program specifically targets jurisdictions in the Pacific Islands, including domestic territories and freely associated states, reflecting a focused geographic intent to strengthen healthcare delivery in areas with unique access challenges. The primary purpose of the program is to provide funding to eligible jurisdictions to develop, enhance, and sustain comprehensive systems of high quality HIV care and treatment for low income individuals living with HIV. This includes expanding access to medical services, improving coordination of care, and ensuring availability of life saving medications through AIDS Drug Assistance Programs. Funding is intended to support systemic improvements that increase retention in care, improve health outcomes, and reduce disparities in access to HIV related services. Allowable uses of funds generally include activities that strengthen healthcare infrastructure, improve service delivery systems, and expand access to medications and treatment services. While specific cost categories are not enumerated in the provided information, the program aligns with federal HIV care priorities, which typically emphasize patient centered care, medication adherence, and integration of supportive services. A cost sharing or matching requirement is indicated, meaning recipients are expected to contribute non federal resources toward program implementation, although the exact ratio or percentage is not specified in the available material. Eligibility is limited to domestic territories and freely associated states, indicating that only governmental or jurisdiction level entities within those geographic categories may apply. The program is not open to nonprofits, private entities, or individuals unless they are acting through eligible governmental jurisdictions. This restriction ensures that funds are administered at a systems level rather than through individual organizations, supporting coordinated public health responses. The application process is expected to follow standard federal grant submission procedures through electronic systems, with applications required to be submitted by the stated deadline. The estimated application due date is October 30, 2026, with submissions required by 11:59 PM Eastern Time. The opportunity is currently in a forecasted stage, with an estimated posting date of August 31, 2026. Applicants should prepare in advance for federal compliance requirements, including registration in applicable systems and completion of required application forms and narratives. The anticipated award date and project start date are both April 1, 2027, indicating a synchronized timeline for funding distribution and program implementation. The total estimated program funding is 300000 dollars, with approximately five awards expected. While specific award ceilings and floors are not defined in the provided information, funding will be distributed across eligible jurisdictions based on formula and supplemental considerations. Contact for the program is Erin Nortrup at HRSA, who can be reached via email or phone for additional guidance. The program appears to follow a recurring federal funding structure tied to fiscal year cycles, though explicit recurrence language is not stated.